SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-014482
Filing Date
2023-08-10
Accepted
2023-08-10 16:02:18
Documents
15
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ganx-20230810x8k.htm   iXBRL 8-K 29864
2 EX-99.1 ganx-20230810xex99d1.htm EX-99.1 186576
3 GRAPHIC ganx-20230810xex99d1001.jpg GRAPHIC 6126
  Complete submission text file 0001558370-23-014482.txt   369539

Data Files

Seq Description Document Type Size
4 EX-101.SCH ganx-20230810.xsd EX-101.SCH 3828
5 EX-101.DEF ganx-20230810_def.xml EX-101.DEF 2827
6 EX-101.LAB ganx-20230810_lab.xml EX-101.LAB 17908
7 EX-101.PRE ganx-20230810_pre.xml EX-101.PRE 10619
9 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20230810x8k_htm.xml XML 5028
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 231159160
SIC: 2834 Pharmaceutical Preparations